Financial News

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market

by
News PRO
January 11, 2026

Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated for U.S. approval later this year.Read More

Related

Related Topics

More in Financial News

Trump administration officials to meet with Danish officials about Greenland on Wednesday, sources say

Trump administration officials are set to meet with Danish officials about Greenland on Wednesday,...
Allegiant to buy rival budget airline Sun Country in $1.5 billion cash and stock deal

Budget airlines in the U.S. like Allegiant and Sun Country have faced a surge...
2 men killed in avalanche near Longs Pass trail in Washington state, 2 rescued

Two men were killed in an avalanche in central Washington state on Friday, and...
Here are the 3 big things we’re watching in the stock market in the week ahead

The new year on Wall Street officially kicks into high gear this week.Read More

An Alabama mom was near death from lead poisoning. Who was trying to kill her, and why?

Iran rachets up warnings against protesters, threatens U.S. troops in region as unrest enters its second week